Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)

被引:205
作者
Maschke, M
Kastrup, O
Esser, S
Ross, B
Hengge, U
Hufnagel, A
机构
[1] Univ Clin Essen, Dept Neurol, D-45122 Essen, Germany
[2] Dept Dermatol, Essen, Germany
[3] Dept Internal Med, Essen, Germany
关键词
HIV; highly active antiretroviral therapy; HIV associated dementia; toxoplasma encephalitis; incidence; prevalence;
D O I
10.1136/jnnp.69.3.376
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective-To determine the change of incidence and prevalence of neurological disorders caused by the human immuno-deficiency virus (HIV) and opportunistic infections in HIV positive patients under treatment since the introduction of highly active antiretroviral therapy (HAART). Methods The data of all HIV infected patients were retrospectively analysed, who were examined in the HIV outpatients clinic of the neurological department of the University Clinic Essen between 1995 and 1998 (n=563, total number of visits - =735). Data from identified patients were divided into two groups according to the time of examination from 1995 to 1996 (334 visits) and from 1997 to 1998 (401 visits). The incidence and prevalence of neurological disorders were statistically compared between both time intervals. Results-Significantly more patients received HAART in 1997-8 (p<0.001) and mean CD4+ cell count was significantly higher in 1997-8 (p<0.001). The prevalence of HIV associated dementia and HIV associated polyneuropathy were significantly lower in 1997-8 (both: p=0.02) and the incidence of toxoplasma encephalitis decreased from 5.7% in 1995-6 to 2.2% in 1997-8 (p=0.015). Based on the small number of patients significant changes in HIV associated myopathy, progressive multifocal leukoencephalopathy, cryptoccocal meningitis, and cytomegalovirus-encephalitis could not be detected. Conclusion-The prevalence of the most frequent HIV associated neurological disorders and incidence of toxoplasma encephalitis decreased since the introduction of HAART. This may be due to the improvement of immunostatus by HAART as demonstrated by the higher CD4+ cell. count in the later time interval. Direct antiretroviral effects within the nervous system may be considered causative as well. The prevalence and incidence of HIV associated neurological disorders and opportunistic CNS infections decreased after introduction of HAART.
引用
收藏
页码:376 / 380
页数:5
相关论文
共 21 条
[11]  
Janssen Robert S., 1997, P13
[12]   EPIDEMIOLOGY OF HUMAN-IMMUNODEFICIENCY-VIRUS ENCEPHALOPATHY IN THE UNITED-STATES [J].
JANSSEN, RS ;
NWANYANWU, OC ;
SELIK, RM ;
STEHRGREEN, JK .
NEUROLOGY, 1992, 42 (08) :1472-1476
[13]   HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND THE NERVOUS-SYSTEM - REPORT FROM THE AMERICAN-ACADEMY-OF-NEUROLOGY AIDS TASK-FORCE [J].
JANSSEN, RS .
NEUROLOGY, 1989, 39 (01) :119-122
[14]  
LEVY RM, 1988, J ACQ IMMUN DEF SYND, V1, P31
[15]   HIV-1 peripheral neuropathy and combination antiretroviral therapy [J].
Markus, R ;
Brew, BJ .
LANCET, 1998, 352 (9144) :1906-1907
[16]  
MICHAELS J, 1998, 5 C RETR OPP INF CHI
[17]  
Sacktor N, 1999, NEUROLOGY, V52, pA252
[18]   Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men [J].
Sacktor, NC ;
Lyles, RH ;
Skolasky, RL ;
Anderson, DE ;
McArthur, JC ;
McFarlane, G ;
Selnes, OA ;
Becker, JT ;
Cohen, B ;
Wesch, J ;
Miller, EN .
NEUROLOGY, 1999, 52 (08) :1640-1647
[19]   CHANGES IN THE SPECTRUM OF AIDS-DEFINING CONDITIONS AND DECREASE IN CD4+ LYMPHOCYTE COUNTS AT AIDS MANIFESTATION IN GERMANY FROM 1986 TO 1991 [J].
SCHWARTLANDER, B ;
HORSBURGH, CR ;
HAMOUDA, O ;
SKARABIS, H ;
KOCH, MA .
AIDS, 1992, 6 (04) :413-420
[20]   PERIPHERAL NEUROPATHY ASSOCIATED WITH ACQUIRED IMMUNODEFICIENCY SYNDROME - PREVALENCE AND CLINICAL-FEATURES FROM A POPULATION-BASED SURVEY [J].
SO, YT ;
HOLTZMAN, DM ;
ABRAMS, DI ;
OLNEY, RK .
ARCHIVES OF NEUROLOGY, 1988, 45 (09) :945-948